#7 MedImmune
1 Medimmune Way
Gaithersburg, MD 20878
Tel: (877) 633-4411
Fax: (301) 398-9000
www.medimmune.com
| Headcount |
2,215 |
|
| Year Established |
1988 |
|
| Biopharma Revenues |
$1,221 |
+9% |
| Total Revenues |
$1,244 |
+9% |
| Royalty Revenues |
$23 |
+35% |
| Net Loss |
-$17 |
n/a |
| R&D Budget |
$385 |
+18% |
Drugs Pending Approval
|
| Drug |
Indication |
medi-545
|
lupus
|
| caiv-t |
refrigerator-stable formulation of FluMist |
| Drugs in Phase IIb and Beyond |
| Drug |
Indication
|
numax Mab
|
lower respiratory tract disease from RSV
|
epstein-barr vaccine
|
Epstein-Barr virus |
abegrin
|
prostate cancer, melanoma |
| HPV vaccine |
cervical cancer from HPV |
ethyol
|
mucositis
|
Early Research Projects
|
| Drug |
Indication |
rsv vaccine
|
respiratory syncytial virus
|
| vaccine programs |
hMPV and PIV-3 |
| mt-103 |
B-cell lymphoma and leukemia |
| ephA2 |
oncology |
| ephA4 |
pancreatic cancer |
hMGB-1
|
rheumatoid arthritis |
siplizumab
|
T-cell lymphoma |
Top Selling Drugs
|
| Drug |
Indication
|
Sales
|
(+/-%)
|
synagis
|
respiratory syncytial virus |
$1,063 |
+13% |
ethyol
|
renal toxicity from chemotherapy
|
$95 |
+3% |
flumist
|
influenza
|
$21 |
-56% |
Account for 97% of total biopharma sales, up from 96% in 2004.
|
